Welcome to ImmCeRNA

ImmCeRNA (Prediction and Evaluation of Immune-related ceRNA for Personalized Therapy and Prognosis in Pan-cancer), which offers an in-depth identification and exploration of immune-related ceRNAs and their close relationship with immune cell infiltration, immunotherapy, drug sensitivity, and cancer prognosis across 27 human cancer types in a cancer-specific, pan-cancer comparative, and patient individual-specific manner. Through this, it facilitates a better comprehension of the intricate interactions within the tumor microenvironment and contributes to the advancement of personalized medicine and improved patient outcomes.

e.g. ceRNA:" HOTAIR-MIR221-ACTG1 " Cancer: " BRCA "

A tool to identify differentially expressed immune-related ceRNAs in pan-cancer.

Start:

A tool for immune cell infiltration analysis of immune-related ceRNAs in pan-cancer.

Start:

A tool to identify dysregulated functions of immune-related ceRNA in pan-cancer based on Gene Ontology and biological pathways.

Start:

A tool to identify immune-related ceRNAs associated with drug sensitivity in pan-cancer.

Start:

A tool to perform COX regression analysis and survival curves for ceRNAs across more than 20 types of malignant cancers.

Start:

A tool to identify immunotherapy-associated
ceRNAs in bulk datasets and single-cell datasets.

Start:

A tool to analysis ceRNAs in Pseudotime Trajectory.

Start:

A tool to identify patient-specific
ceRNA and clinical drug responses.

Start:

A tool to identify associated transcription factors (TFs) by ceRNA.

Start:

A tool to identify ceRNA in Spatial Transcriptomic Data

Start:

A tool to analyze CRISPR gene knockouts in ceRNA.

Start:

We developed an XGBoost-based prediction model for pan-cancer immunotherapy response.

Start:

Visits/Contact Us

For questions, problems, comments on the database, please send a mail to wangli@hrbmu.edu.cn